teclistamab
janssen,genmab
['mmsm']
a great new t-cell redirecting treatment option is in clinical trials and may make it to clinics soon. #mmsm #asco22 #eha2022 #myeloma 
Retired Teacher- Dx with Myeloma 2008- Patient Research Advocate-Curriculum Director @HealthTreeU- @ASH_Hematology & @TheEBMT Speaker-IRB Member, #MMSM